![Tracey Sacco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tracey Sacco
Geen lopende functies
Vermogen: 4 M $ op 31-05-2026
Profiel
Tracey Sacco worked at Acceleron Pharma, Inc. from 2012 to 2021 as SVP-Global Marketing & Alliance Management.
Ms. Sacco worked at Scholar Rock Holding Corp.
from 2023 to 2025 as Chief Commercial Officer.
Ms. Sacco completed undergraduate studies at Boston College and earned an MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-04-2025 | 71.750 ( 0,06% ) | 4 M $ | 31-05-2026 |
Eerdere bekende functies van Tracey Sacco
| Bedrijven | Functie | Einde |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 01-06-2025 |
| ACCELERON PHARMA INC. | Verkoop & Marketing | 01-09-2021 |
Opleiding van Tracey Sacco
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
